Here’s what you should know:
1. Olympus alleged Cantel Medical’s AmplifEye endoscopic device infringed on its patent for the Endocuff single-use device in the lawsuit, according to a March 22 news release. Olympus acquired the technology and patents after acquiring Arc Medical Design in 2020.
2. Olympus is seeking an injunction against further sales of AmplifEye in the U.S.
3. Courts in the United Kingdom ruled that AmplifEye infringed on Olympus’ patents.
Note: Cantel/Medivators didn’t immediately respond to a request for comment. This story will be updated if we hear back.
More articles on surgery centers:
States with the most ASC activity in Q1
7 updates on cardiology and ASCs in 2021
4 key questions on the future of spine surgery at ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.